The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions

Cytopathology

Volumn 19, Issue 4, 2008, Pages 218-223

  Shield, P W ^a   Koivurinne, K ^a,b  

^a Sullivan Nicolaides Pathology   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Adenocarcinoma; Calretinin; Cytodiagnosis; Cytokeratin 5 6; Cytology; Effusion; Immunocytochemistry; Mesothelioma

Indexed keywords

CALRETININ; CYTOKERATIN 5; CYTOKERATIN 6; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; TUMOR MARKER;

ADENOCARCINOMA; ARTICLE; ASCITES FLUID CYTOLOGY; BREAST CARCINOMA; CANCER CYTODIAGNOSIS; CANCER OF UNKNOWN PRIMARY SITE; COLON CARCINOMA; CYTOLOGY; DIAGNOSTIC VALUE; EFFUSION; ENDOMETRIUM CARCINOMA; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MESOTHELIOMA; METASTASIS; OVARY CARCINOMA; PANCREAS CARCINOMA; PERITONEAL FLUID; PRIORITY JOURNAL; STOMACH CARCINOMA;

CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; HUMANS; KERATIN-5; KERATIN-6; MESOTHELIOMA; NEOPLASMS; PLEURAL EFFUSION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STAINING AND LABELING; TUMOR MARKERS, BIOLOGICAL;

EID: 46749100990     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2007.00482.x     Document Type: Article

References (21)

1. Whitaker D. Invited review: the cytology of malignant mesothelioma. Cytopathology 2000 11 : 139 51.
2. Shield PW, Perkins G, Wright RG. Immnocytochemical staining of cytologic specimens: How helpful is it? Am J Clin Pathol 1996 105 : 157 62.
3. Shield PW, Callan JJ, Devine PL. Markers for metastatic adenocarcinoma in serous effusion specimens. Diagn Cytopathol 1994 11 : 237 45.
4. Rogers J. Calretinin: a gene for a novel calcium binding protein expressed principally in neurons. J Cell Biol 1987 105 : 1343 53.
5. Doglioni C, Dei Tos AP, Lurino L et al. Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 1996 20 : 1037 46.
6. King JE, Thatcher N, Pickering CAC, Hasleton PS. Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published data. Histopathology 2006 48 : 223 32.
7. Simisar A, Fetsch P, Mehta D, Zabowski, Abati A. E-cadherin, N-cadherin and calretinin in pleural effusions: the good, the bad and the worthless. Diagn Cytopathol 1999 20 : 125 30.
8. Chhieng DC, Yee H, Schaefer D et al. Calretinin staining pattern aids in the differentiation of mesothelioma from adenocarcinoma in serous effusions. Cancer 2000 90 : 194 200.
9. Davidson B, Nielsen S, Christensen J et al. The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells. Am J Surg Pathol 2001 25 : 1405 12.
10. Fetsch PA, Simsar A, Abati A. Comparison of antibodies to HBME-1 and calretinin for the detection of mesothelial cells in effusion specimens. Diagn Cytopathol 2001 25 : 158 61.
11. Lucchi I, Morigi F, Naldi S, Tabarri B, Elegibili E, Giangaspero F. Cell block immunocytochemical characterization of effusions. Use of antibody panel: calretinin, Ber-Ep4, keratin and CD68. Pathologica 1999 91 : 447 52.
12. Kitazume H, Kitamura K, Mukai K et al. Cytologic differential diagnosis among reactive mesothelioma cells, malignant mesothelioma and adenocarcinoma. Utility of combined E-cadherin and calretinin immunostaining. Cancer (Cancer Cytopathol) 2000 90 : 55 60.
13. Wieczorek TJ, Krane JF. Diagnostic utility of calretinin immunohistochemistry in cytologic cell block preparations. Cancer (Cancer Cytopathol) 2000 90 : 312 9.
14. Miettinen M. Keratin immunochemistry: an update on applications and pitfalls. Pathol Annu 1993 28 : 113 43.
15. Ordonez NG. Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma. Am J Surg Pathol 1998 22 : 1215 21.
16. Cury PM, Butcher DN, Fisher C, Corrin B, Nicholson AG. Value of mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD 44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura. Mod Pathol 2000 13 : 107 12.
17. Chu PG, Weiss LM. Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases. Mod Pathol 2002 15 : 6 10.
18. Abutaily AS, Addis BJ, Roche WR. Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies. J Clin Pathol 2002 55 : 662 8.
19. Han J, Kim M-K, Nam S-J, Yang J-H. E-cadherin and cytokeratin subtype profiling in effusion cytology. J Korean Med Sci 2004 19 : 826 33.
20. Gill SA, Meier PA, Kendall BS. Use of desmin immunohistochemistry to distinguish between mesothelial cells and carcinoma in serous fluid cell block preparations. Acta Cytol 2000 44 : 976 80.
21. Hecht JL, Lee BH, Pinkus JL, Pinkus GS. The value of Wilms tumour susceptibility gene 1 in cytologic preparations as a marker for malignant mesothelioma. Cancer 2002 96 : 105 9.